在乳腺癌细胞中对假定的HER2相关表达增强剂Her2-Enhancer1的功能分析

Mahdieh Rojhannezhad1, Bahram M Soltani1, Mohammad Vasei2

  • 1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

Scientific reports
|November 9, 2023
PubMed
概括

研究人员使用CRISPR/Cas9来禁用HER2增强剂,减少HER2的表达并增加癌细胞的亡. 这突出了HER2阳性癌症的潜在新治疗点.